GNMX - Aevi Genomic Medicine, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.63M
Enterprise Value 34.47M
Trailing P/E N/A
Forward P/E 1-0.30
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.42
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.17

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-96.56%
Return on Equity (ttm)-203.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -27.02M
Net Income Avi to Common (ttm)-26.91M
Diluted EPS (ttm)-0.4290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.95M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)11k
Total Debt/Equity (mrq)0.30
Current Ratio (mrq)1.95
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-24.53M
Levered Free Cash Flow (ttm)-14.59M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.62
52-Week Change 3-84.56%
S&P500 52-Week Change 35.62%
52 Week High 31.4000
52 Week Low 30.1500
50-Day Moving Average 30.2017
200-Day Moving Average 30.3290

Share Statistics

Avg Vol (3 month) 31.49M
Avg Vol (10 day) 3439.33k
Shares Outstanding 564.77M
Float 54.55M
% Held by Insiders 142.43%
% Held by Institutions 119.10%
Shares Short (May 31, 2019) 4371.89k
Short Ratio (May 31, 2019) 40.21
Short % of Float (May 31, 2019) 40.90%
Short % of Shares Outstanding (May 31, 2019) 40.57%
Shares Short (prior month Apr 30, 2019) 4189.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A